Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label, Phase II Studies
评估雷莫芦单抗单药或联合紫杉醇二线治疗局部晚期或转移性胃/胃食管交界处腺癌的替代剂量：两项随机、开放标签 II 期研究的结果
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers14051168
Shah, Manish A; Udrea, Anghel Adrian; Bondarenko, Igor; Mansoor, Was; Sánchez, Raquel Guardeño; Sarosiek, Tomasz; Bozzarelli, Silvia; Schenker, Michael; Gomez-Martin, Carlos; Morgan, Carys; Özgüroğlu, Mustafa; Pikiel, Joanna; Kalofonos, Haralabos P; Wojcik, Elzbieta; Buchler, Tomas; Swinson, Daniel; Cicin, Irfan; Joseph, Mano; Vynnychenko, Ihor; Luft, Alexander Valerievich; Enzinger, Peter C; Salek, Tomas; Papandreou, Christos; Tournigand, Christophe; Maiello, Evaristo; Wei, Ran; Ferry, David; Gao, Ling; Oliveira, Joana M; Ajani, Jaffer A
